Both in Biotechnology
SAB Biotherapeutics vs Agenus
Over the past year SABS returned +1.1% and AGEN returned +75.3%; their daily moves had a correlation of 0.19.
SABS +1.1% AGEN +75.3%Growth of $1, one year, split-adjusted
| Metric | SABS | AGEN |
|---|---|---|
| Price | $3.29 | $6.96 |
| Market cap | $298.9M | $314.3M |
| Today | +5.29% | +4.35% |
| 1 month | +12.1% | −7.1% |
| 6 months | −13.6% | +78.9% |
| Year to date | −12.2% | +121.7% |
| 1 year | +1.1% | +75.3% |
| Revenue growth (YoY) | — | +34.4% |
| Gross margin | — | 100.0% |
| Net margin | — | −1.7% |
| P/E (TTM) | — | 3.4× |
| Price / sales | — | 2.4× |
| Net cash | $99.4M | -$11.3M |
| Dividend yield | — | — |
| Volatility (60d) | 57.5% | 88.8% |
| Short % of float | 6.2% | 16.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).